We are live on ! Find out more
MAM

Martingale Asset Management Portfolio holdings

AUM $3.99B
1-Year Est. Return 22.65%
This Fund
S&P 500
This Quarter Est. Return
-5.21%
1 Year Est. Return
+22.65%
3 Year Est. Return
+77.2%
5 Year Est. Return
+114.11%
10 Year Est. Return
+351.19%
AUM
$5.02B
AUM Growth
-$481M
Cap. Flow
-$151M
Cap. Flow %
-3.01%
Top 10 Hldgs %
12.65%
Holding
930
New
93
Increased
368
Reduced
299
Closed
113

Sector Composition

Rank Sector Weight
1 Healthcare 21.18%
2 Technology 18.59%
3 Consumer Staples 12.68%
4 Financials 12.23%
5 Industrials 11.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NATR icon
651
Nature's Sunshine
NATR
$358M
$416K 0.01%
50,402
+12,222
+32% +$121K
OI icon
652
O-I Glass
OI
$1.09B
$416K 0.01%
+32,115
New +$435K
CAC icon
653
Camden National
CAC
$992M
$414K 0.01%
9,700
-2,200
-18% -$99.9K
UFPT icon
654
UFP Technologies
UFPT
$2.41B
$413K 0.01%
4,804
BBIO icon
655
BridgeBio Pharma
BBIO
$16.2B
$412K 0.01%
41,375
+1,694
+4% +$17.6K
NRG icon
656
NRG Energy
NRG
$25B
$411K 0.01%
+10,724
New +$428K
PR
657
Permian Resources
PR
$17B
$411K 0.01%
60,431
BGC icon
658
BGC Group
BGC
$4.97B
$409K 0.01%
130,165
+7
+0% +$27
FRPH icon
659
FRP Holdings
FRPH
$407M
$407K 0.01%
14,924
+600
+4% +$17.5K
CSV icon
660
Carriage Services
CSV
$587M
$406K 0.01%
12,609
-8,709
-41% -$325K
NRC icon
661
NRC Health Common Stock
NRC
$431M
$403K 0.01%
10,105
+700
+7% +$25.9K
CGEM icon
662
Cullinan Oncology
CGEM
$1.16B
$398K 0.01%
+31,016
New +$418K
GBIO
663
DELISTED
Generation Bio
GBIO
$395K 0.01%
7,430
-1
-0% -$63
PINC
664
DELISTED
Premier
PINC
$393K 0.01%
11,554
+514
+5% +$18.7K
IMVT icon
665
Immunovant
IMVT
$8.21B
$392K 0.01%
70,138
+74
+0.1% +$362
EGRX
666
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$391K 0.01%
14,756
+651
+5% +$23.9K
COLL icon
667
Collegium Pharmaceutical
COLL
$944M
$390K 0.01%
24,313
+7,887
+48% +$139K
CABO icon
668
Cable One
CABO
$252M
$389K 0.01%
456
-2,312
-84% -$2.85M
NABL icon
669
N-able
NABL
$917M
$388K 0.01%
+42,024
New +$409K
PLPC icon
670
Preformed Line Products
PLPC
$2.25B
$386K 0.01%
5,423
+3
+0.1% +$211
P
671
Everpure Inc
P
$29B
$385K 0.01%
+14,034
New +$397K
TEAM icon
672
Atlassian
TEAM
$28B
$383K 0.01%
1,814
-1,887
-51% -$441K
MOD icon
673
Modine Manufacturing
MOD
$10.2B
$382K 0.01%
+29,508
New +$414K
GOOG icon
674
Alphabet (Google) Class C
GOOG
$4.36T
$379K 0.01%
3,940
-20
-0.5% -$2.23K
CNDT icon
675
Conduent
CNDT
$271M
$374K 0.01%
111,752
+2,937
+3% +$12.3K

Similar funds

Martingale Asset Management's Q3 2022 Portfolio in Review

As of Q3 2022, Martingale Asset Management held 930 positions worth $5.02B, down 8.7% from $5.5B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Martingale Asset Management withdrew a net $151M in Q3 2022, closing 113 positions and reducing 299 holdings. Its most notable exit was Alleghany Corp, an estimated $13.2M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 21% a quarter earlier, followed by Technology and Consumer Staples.

Against the trend, Martingale Asset Management opened a new position in Huntington Ingalls Industries worth $20.8M.

  • Martingale Asset Management's largest Q3 2022 buy was Huntington Ingalls Industries: 93,777 shares worth $20.8M.
  • Martingale Asset Management added most to CVS Health in Q3 2022, an estimated $27M increase.
  • Martingale Asset Management's biggest Q3 2022 reduction was Prologis, cutting an estimated $28M.
  • Martingale Asset Management fully exited Alleghany Corp in Q3 2022, selling an estimated $13.2M.
  • Martingale Asset Management's ten largest holdings make up 13% of its $5.02B portfolio in Q3 2022.
  • Martingale Asset Management opened 93 new positions and closed 113 in Q3 2022.
  • Martingale Asset Management's portfolio value fell 8.7% quarter-over-quarter to $5.02B.

Based on Martingale Asset Management's 13F filing for Q3 2022, filed 14 Nov 2022.